When looking for stocks that combine strong earnings momentum with a good technical setup, the High Growth Momentum (HGM) Rating is a useful tool. This rating evaluates a company based on key metrics favored by growth investors—earnings and sales growth, acceleration, profit margins, estimate revisions, and surprise history. When a stock also scores highly on both the ChartMill Technical Rating (which measures overall technical health) and the Setup Quality Rating (which identifies favorable consolidation patterns), it can present a strong candidate for a breakout trade. Globus Medical Inc - A (NYSE:GMED) is one such stock that currently meets all three thresholds, making it worth a closer look.
High Growth Momentum Fundamentals
Globus Medical’s HGM Rating of 6 out of 10 reflects solid, though not perfect, growth characteristics. For context, scores of 5 and above can already point to interesting opportunities, and a 6 signals a company with several strong growth pillars in place. Here’s a breakdown of the numbers driving that rating:
- Earnings Momentum: EPS growth has been accelerating sharply. The most recent quarter (Q2Q) saw EPS growth of 52.38%, up from 42.17% in the prior quarter and 14.67% two quarters ago. This acceleration is a core element of the HGM methodology.
- Sales Growth: Revenue growth is also strong and accelerating. The latest quarter posted 25.73% sales growth, compared to 22.91% and 18.37% in the two preceding quarters.
- Estimate Revisions: Analysts are becoming more optimistic. The average estimate for next year’s EPS has been revised upward by 8.44% over the last three months, and revenue estimates have risen by 1.68%. This positive revision trend is a key input to the HGM rating.
- Earnings Surprises: GMED has beaten EPS estimates in 3 of the last 4 quarters, with an average beat of 14.55%. This consistency in surprising to the upside reinforces earnings momentum.
- Profit Margin Expansion: The profit margin has expanded from 15.47% last quarter to 17.01% in the most recent quarter, another positive signal that the company is becoming more efficient.
These factors—accelerating earnings and sales, positive analyst revisions, and expanding margins—are precisely the characteristics that high growth momentum investors look for. The HGM rating condenses all this data into a single score, helping to identify stocks that are gaining fundamental traction.
Technical Strength and Setup Quality
Beyond the fundamental story, GMED also shows strong technical health. The ChartMill Technical Rating of 8 out of 10 indicates the stock is in a solid uptrend. Both the short-term and long-term trends are positive, which aligns with the overall positive trend in the S&P 500. The stock is currently trading near the high end of its recent monthly range and outperforms 82% of stocks in the Health Care Equipment & Supplies industry.
Equally important is the Setup Quality Rating of 8 out of 10. This score suggests GMED is forming a constructive consolidation pattern. According to the technical analysis report, a pullback is taking place within a tight range, which can offer a favorable entry point. There is a resistance zone just above the current price, and a support zone below, providing a clear framework for risk management. A recent Pocket Pivot signal, a price/volume accumulation pattern, adds further confidence to the setup.
A Potential Trading Framework
The combination of a strong fundamental momentum profile and a high-quality technical setup creates a classic growth breakout opportunity. Based on the support and resistance levels identified in the technical report, a potential trade could look like this:
- Suggested Entry: Above the resistance zone at $96.83 (using a buy stop order).
- Suggested Stop Loss: Below the support zone at $89.46 (using a stop loss order).
- Risk per Share: $7.37 (approximately 7.61% of the entry price).
- Position Sizing: For a 1% total portfolio risk, an allocation of roughly 13.14% of capital could be considered.
Note: This is an automatically generated suggestion and should not be interpreted as trading advice. Always conduct your own analysis and consider upcoming events or earnings reports.
For investors interested in discovering more stocks that combine high growth momentum with strong technical setups, you can run the same screen used to find GMED. Click here to access the full list of current candidates.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Trading in stocks involves risk, and past performance is not indicative of future results. Always conduct your own research before making any investment decisions.